Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

The effect of ageing on macrophage Toll-like receptor-mediated responses in the fight against pathogens.

Dunston CR, Griffiths HR.

Clin Exp Immunol. 2010 Sep;161(3):407-16. doi: 10.1111/j.1365-2249.2010.04213.x. Review.

2.
3.

IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

Sirén J, Pirhonen J, Julkunen I, Matikainen S.

J Immunol. 2005 Feb 15;174(4):1932-7.

4.
5.

Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.

Hu X, Chen J, Wang L, Ivashkiv LB.

J Leukoc Biol. 2007 Aug;82(2):237-43. Epub 2007 May 14. Review.

PMID:
17502339
6.

Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.

Xu H, An H, Hou J, Han C, Wang P, Yu Y, Cao X.

Mol Immunol. 2008 Aug;45(13):3545-52. doi: 10.1016/j.molimm.2008.05.006. Epub 2008 Jun 20.

PMID:
18571728
7.

Toll-like receptors and their signaling mechanism in innate immunity.

Kaisho T, Akira S.

Acta Odontol Scand. 2001 Jun;59(3):124-30. Review.

PMID:
11501880
8.

Cumulative Toll-like receptor activation in human macrophages treated with whole bacteria.

Nau GJ, Schlesinger A, Richmond JF, Young RA.

J Immunol. 2003 May 15;170(10):5203-9.

9.

Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.

Ruckdeschel K, Pfaffinger G, Haase R, Sing A, Weighardt H, Häcker G, Holzmann B, Heesemann J.

J Immunol. 2004 Sep 1;173(5):3320-8.

10.

[Innate immunity: structure and function of TLRs].

Delneste Y, Beauvillain C, Jeannin P.

Med Sci (Paris). 2007 Jan;23(1):67-73. French.

11.

A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.

De Nardo D, Masendycz P, Ho S, Cross M, Fleetwood AJ, Reynolds EC, Hamilton JA, Scholz GM.

J Biol Chem. 2005 Mar 18;280(11):9813-22. Epub 2005 Jan 12.

12.

The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.

Horng T, Barton GM, Flavell RA, Medzhitov R.

Nature. 2002 Nov 21;420(6913):329-33.

PMID:
12447442
13.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
14.
15.

Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection.

Chandra AP, Ouyang L, Yi S, Wong JK, Ha H, Walters SN, Patel AT, Stokes R, Jardine M, Hawthorne WJ, O'Connell PJ.

Xenotransplantation. 2007 Jan;14(1):48-59.

PMID:
17214704
16.

Toll like receptor signaling in "inflammaging": microRNA as new players.

Olivieri F, Rippo MR, Prattichizzo F, Babini L, Graciotti L, Recchioni R, Procopio AD.

Immun Ageing. 2013 Mar 19;10(1):11. doi: 10.1186/1742-4933-10-11.

17.

Monocyte and macrophage heterogeneity and Toll-like receptors in the lung.

Schneberger D, Aharonson-Raz K, Singh B.

Cell Tissue Res. 2011 Jan;343(1):97-106. doi: 10.1007/s00441-010-1032-2. Epub 2010 Sep 8. Review.

PMID:
20824285
18.

T cell-dependent and -independent IgA responses: role of TLR signalling.

Bessa J, Bachmann MF.

Immunol Invest. 2010;39(4-5):407-28. doi: 10.3109/08820131003663357. Review.

PMID:
20450285
19.

The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.

Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A.

J Hepatol. 2011 Oct;55(4):762-9. doi: 10.1016/j.jhep.2010.12.042. Epub 2011 Feb 18.

PMID:
21334391
20.

MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.

Reiling N, Ehlers S, Hölscher C.

Immunol Lett. 2008 Feb 15;116(1):15-23. doi: 10.1016/j.imlet.2007.11.015. Epub 2007 Dec 26. Review.

PMID:
18191460

Supplemental Content

Support Center